Hazard Information | Back Directory | [Clinical Use]
Monoclonal antibody:
Treatment of advanced soft tissue sarcoma in
combination with doxorubicin | [Drug interactions]
Potentially hazardous interactions with other drugs
Live vaccines: avoid with olaratumab in combination
with doxorubicin. | [Metabolism]
Mainly degraded non-specifically by proteolytic enzymes. |
|
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Website: |
https://www.bocsci.com |
Company Name: |
Biolab Reagents
|
Tel: |
027-65279366 18108604862 |
Website: |
www.biolabreagent.com/ |
|